1.
J Neurol
; 257(4): 655-7, 2010 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19960199
RESUMO
We report a successful treatment with rituximab in a patient with CANOMAD neuropathy resistant to previous therapy. The titers of anti-disialosyl antibodies were decreased 3 months after the beginning of the treatment and the sensory ataxia clearly improved after 9 months of therapy.